In 2013, we introduced our first generic product, Etodolac, to the market. Since Etodolac we have added a number of products, and we expect that the development of generic products will accelerate in the years to come. If you have a generic product that you want to develop together with a competent partner, 2care4 is the right choice. You can choose to develop generic medicine as co-development, or you can choose to let us handle the sales by out licensing your MA to us. When you choose us we can quickly assess the potential of a given product on the Scandinavian market – and we know the regulatory requirements.
Are you looking for a business partner to develop generic medicine?
Take the first step and contact us.